Improving syphilis screening using a new testing method
Evaluation of a Treponema pallidum transcription mediated amplification assay for Syphilis Screening
This study is testing a new way to quickly detect syphilis in men who have sex with men and transgender individuals, using different types of samples like blood and rectal swabs, to help find infections earlier than current tests do.
Quick facts
| Grant type | R01 grant |
|---|---|
| Study type | NIH-funded research |
| Funding institution | University of Washington NIH-funded |
| Lab location | 1 site (Seattle, United States) |
| Project ID | NIH-11142569 on NIH RePORTER |
What this research studies
This research investigates a novel transcription mediated amplification (TMA) assay for detecting syphilis, particularly among men who have sex with men and transgender individuals. The study aims to identify syphilis infections earlier than traditional serological tests, which can take weeks to show positive results. By analyzing various specimen types, including blood and rectal samples, the research seeks to determine the most effective methods for early detection of the infection. This could lead to better management and treatment of syphilis in affected populations.
Who could benefit from this research
Good fit: Ideal candidates for this research include men who have sex with men and transgender individuals who are at risk for syphilis infection.
Not a fit: Patients who are not at risk for syphilis or those who have already been diagnosed and treated for the infection may not benefit from this research.
Why it matters
Potential benefit: If successful, this research could lead to earlier detection and treatment of syphilis, reducing transmission rates and improving health outcomes.
How similar studies have performed: Previous research has shown promise in using similar amplification techniques for other infections, suggesting potential for success in this novel application.
Where this research is happening
Seattle, United States
- University of Washington — Seattle, United States (Active)
Researchers
- Principal investigator: Golden, Matthew R — University of Washington
- Study coordinator: Golden, Matthew R
About this research
- This is an active NIH-funded research project — typically early-stage science, not a clinical trial accepting patient enrollment.
- Some NIH-funded labs run parallel clinical studies or seek volunteers for related work. To check, contact the principal investigator or institution listed above.
- For full project details, budget, and progress reports, visit the official NIH RePORTER page below.